Screening of GPCR drugs for repurposing in breast cancerNoor Mazin Abdulkareem, Meghana V. Trivedi, Camille A. Johnson et al.|Frontiers in Pharmacology|2022Cited by 19
Dose-dependent relation between metformin and the risk of hormone receptor-positive, her2-negative breast cancer among postmenopausal women with type-2 diabetesSoumya Chikermane, Michael L. Johnson, Manvi Sharma et al.|Breast Cancer Research and Treatment|2022Cited by 17
Comparing the effects of various β-blockers on cardiovascular mortality in breast cancer patientsMantasha Tabassum, Meghana V. Trivedi, Soumya Chikermane et al.|Cardio-Oncology|2024Cited by 2
PCN130 Dose-Dependent Relation between Metformin and the Risk of Hormone Receptor-Positive, HER2-Negative (HR+/HER2-) Breast Cancer Among Postmenopausal Women with Type-2 DiabetesSoumya Chikermane, Magnus L. Johnson, Meghana V. Trivedi et al.|Value in Health|2021Cited by 0
Abstract P2-11-09: Comparing the effects of various beta blockers on cardiovascular-related mortality in breast cancer patientsNoor Mazin Abdulkareem, Meghana V. Trivedi, Soumya Chikermane et al.|Cancer Research|2022Cited by 0